previous compound ID: 2275 next compound
InChIKey: UWFYSQMTEOIJJG-FDTZYFLXSA-N
SMILES: CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "SD Macknight" "GW Carlile" "B Kus" "E Matthes" "R Robert" "JW Hanrahan" "D Rotin" "J Liao" "J Goepp"

chemical graph of compound 2275




CID is 9880
synonyms found at PubChem are:
CYPROTERONE ACETATE, 427-51-0, Androcur, Cyproterone 17-O-acetate, Cyproteron acetate, Cyproteron-R acetate, Cyprosterone acetate, SH 714, UNII-4KM2BN5JHF, SH 80714, Cyproteroneacetate, Cyproterone 17alpha-acetate, NSC-81430, SH-714, CCRIS 4385, Cyproterone acetate [USAN:JAN], HSDB 3592, EINECS 207-048-3, NSC 81430, 4KM2BN5JHF, C24H29ClO4, Cyproterone 17.alpha.-acetate, MLS000859908, CHEMBL139835, 3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1beta,2beta)-, CHEBI:50743, UWFYSQMTEOIJJG-FDTZYFLXSA-N, NSC81430, 6-Chloro-1beta,2beta-dihydro-17-hydroxy-3'H-cyclopropa(1,2)-pregna-1,4,6-triene-3,20-dione acetate, NCGC00091032-03, DSSTox_CID_366, 6-Chloro-delta-6-1,2alpha-methylene-17alpha-hydroxyprogesterone acetate, 1,2-alpha-Methylene-6-chloro-delta(sup 6)-17-alpha-hydroxyprogesterone acetate, 1,2-alpha-Methylene-6-chloro-pregna-4,6-diene-3,20-dione 17-alpha-acetate, 6-Chloro-1,2-alpha-methylene-6-dehydro-17-alpha-hydroxyprogesterone acetate, 6-Chloro-delta(sup 6)-1,2-alpha-methylene-17-alpha-hydroxyprogesterone acetate, 1,2-alpha-Methylene-6-chloro-(sup 4,6)-pregnadiene-17-alpha-ol-3,20-dione 17-alpha-acetate, 17-alpha-Acetoxy-6-chloro-1-alpha,2-alpha-methylenepregna-4,6-diene-3,20-dione, 6-Chlor-delta(sup 6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteronacetat [German], 6-Chloro-1,2-alpha-methylene-17-alpha-hydroxy-delta(sup 6)-progesterone acetate, 6-Chloro-17-hydroxy-1-alpha,2-alpha-methylenepregna-4,6-diene-3,20-dione acetate, DSSTox_RID_75542, Pregna-4,6-diene-3,20-dione, 6-chloro-17-hydroxy-1-alpha,2-alpha-methylene-, acetate, DSSTox_GSID_20366, (1R,3aS,3bR,7aR,8aS,8bS,8cS,10aS)-1-acetyl-5-chloro-8b,10a-dimethyl-7-oxo-1,2,3,3a,3b,7,7a,8,8a,8b,8c,9,10,10a-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-1-yl acetate, 6-chloro-3,20-dioxo-1beta,2beta-dihydro-3'H-cyclopropa[1,2]pregna-4,6-dien-17-yl acetate, (1S,2S,3S,12S,16S,5R,11R,15R)-15-acetyl-9-chloro-2,16-dimethyl-6-oxopentacyclo [9.7.0.0<2,8>.0<3,5>.0<12,16>]octadeca-7,9-dien-15-yl acetate, 3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 6-chloro-1-beta,2-beta-dihydro-17-hydroxy-, acetate, 6-Chloro-1-beta,2-beta-dihydro-17-hydroxy-3'H-cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione 17-acetate, SMR000326769, SR-01000075755, cyproviron, Cyprostat&reg, (1?,2?)-17-(Acetyloxy)-6-chloro-1,2-dihydro-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione, CAS-427-51-0, 2oz7, cid_9880, SCHEMBL5936, BIDD:PXR0052, Lopac0_000301, MLS001055462, MLS001066353, MLS002207305, MLS006011110, Cyproterone acetate, >=98%, Cyproterone Acetate Impurity F, (non-d)Cyproterone acetate-d5, AC1L1U14, GTPL2865, DTXSID5020366, MolPort-003-940-714, HMS2090A14, HMS2233J06, HMS3260N04, (2aR,3aS,3bS,3cS,5aS,6R,8aS,8bR)-6-acetyl-10-chloro-3b,5a-dimethyl-2-oxo-2,2a,3,3a,3b,3c,4,5,5a,6,7,8,8a,8b-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-6-yl acetate, ZINC3814423, Tox21_111064, Tox21_201686, Tox21_302941, Tox21_500301, AC-929, BDBM50094569, DL-368, s2042, 6-Chlor-delta(sup 6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteronacetat, AKOS008901350, AKOS015895238, Tox21_111064_1, AN-5495, CCG-204396, DB04839, LP00301, NCGC00091032-01, NCGC00091032-04, NCGC00091032-05, NCGC00091032-09, NCGC00256442-01, NCGC00259235-01, NCGC00260986-01, NCGC00262575-02, Progesterone,2.alpha.-methylene, acetate, 3'H-Cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1.beta.,2.beta.)-, BC201848, CC-26170, LS-58799, SC-16128, SMR000686068, ST075180, Progesterone,2.alpha.-methylene-, acetate, (acetyl-chloro-dimethyl-oxo-[?]yl) acetate, AB2000446, 1,6-diene-3,20-dione 17.alpha.-acetate, EU-0100301, C 3412, D01368, 49714-EP2280012A2, 49714-EP2295426A1, 49714-EP2295427A1, 49714-EP2298768A1, 49714-EP2311825A1, AB00698312-08, 1,6)-pregnadeine-17.alpha.-3,20-dione acetate, 427C510, C-22019, SR-01000075755-1, SR-01000075755-4, SR-01000075755-6, W-106262, 1,6)-pregnadiene-17.alpha.-ol-3,20-dione acetate, BRD-K41141507-001-16-2, WLN: L F3 E6 D665 IV JU LUTJ A1 E1 RV1 RQ, 17.alpha.-Acetoxy-6-chloro-1.alpha.,6-diene-3,20-dione, 6-Chloro-17-hydroxy-1.alpha.,6-diene-3,20-dione acetate, 1,6)-pregnadiene-17.alpha.-ol-3,20-dione 17alpha-acetate, 6-Chloro-1.beta.,2]pregna-1,4,6-triene-3,20-dione acetate, Cyproterone acetate, European Pharmacopoeia (EP) Reference Standard, 6-chloro-17-acetoxy-1alpha,2alpha-methylene-4,6-pregnadiene-3,20-dione, 1,2.alpha.-Methylene-6-chloro-.delta.(sup 6)-17.alpha.-hydroxyprogesterone acetate, 17alpha-acetoxy-6-chloro-1alpha,2alpha-methylene-4,6-pregnadiene-3,20-dione, 6-Chloro-.delta.(sup 6)-1,2.alpha.-methylene-17.alpha.-hydroxyprogesterone acetate, 6-Chloro-1,2.alpha.-methylene-17.alpha.-hydroxy-.delta.(sup 6)-progesterone acetate, 6-Chloro-1,2.alpha.-methylene-6-dehydro-17.alpha.-hydroxyprogesterone acetate, Cyproterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard, Pregna-4,20-dione, 6-chloro-17-hydroxy-1.alpha.,2.alpha.-methylene-, acetate, 3'H-Cyclopropa[1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1.beta.,2.beta.)-, 3'H-Cyclopropa[1,4,6-triene-3,20-dione, 6-chloro-1.beta.,2.beta.-dihydro-17-hydroxy-, acetate, 3'H-Cyclopropa[1,4,6-triene-3,20-dione, 6-chloro-1.beta.,2.beta.-dihydro-17-hydroxy-,acetate, 6-chloro-3,20-dioxo-1beta,2beta-dihydro-3''H-cyclopropa[1,2]pregna-4,6-dien-17-yl acetate, acetic acid (8R,9S,10S,13S,14S,17R)-17-acetyl-6-(S)-chloro-10,13-dimethyl-3-(R)-oxo-1,2,3,8,9,10,11,12,13,14,15,16,17,20-tetradecahydro-cyclopropa[1,2]cyclopenta[a]phenanthren-17-yl ester